{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:02:59Z","timestamp":1792843379996,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejso.2024.108733","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:26:21Z","timestamp":1727828781000},"page":"108733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Feasibility of major hepatectomy following preoperative chemotherapy for advanced perihilar cholangiocarcinoma"],"prefix":"10.1016","volume":"51","author":[{"given":"Atsushi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1512-1687","authenticated-orcid":false,"given":"Yoshinori","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fukumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Kotera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Mise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5600-2847","authenticated-orcid":false,"given":"Akio","family":"Saiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10372","key":"10.1016\/j.ejso.2024.108733_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejso.2024.108733_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108733_bib3","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1245\/s10434-023-13913-6","article-title":"A multicenter survey on eligibility for a randomized phase III trial of adjuvant chemotherapy for resected biliary tract cancer (JCOG1202, ASCOT)","volume":"30","author":"Kobayashi","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.108733_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/theoncologist.2009-0152","article-title":"Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver","volume":"14","author":"Cleary","year":"2009","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108733_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.108733_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejso.2012.12.020","article-title":"Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis","volume":"39","author":"Ribeiro","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108733_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejso.2022.08.035","article-title":"Sequential therapy of portal vein embolization and systemic chemotherapy for locally advanced perihilar biliary tract cancer","volume":"49","author":"Takahashi","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108733_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SLA.0000000000004808","article-title":"Proposal of a new comprehensive notation for hepatectomy: the \"new world\" terminology","volume":"274","author":"Nagino","year":"2021","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2024.108733_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","article-title":"Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery","volume":"149","author":"Koch","year":"2011","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ejso.2024.108733_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.ejso.2024.108733_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","article-title":"Post-hepatectomy haemorrhage: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"13","author":"Rahbari","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.ejso.2024.108733_bib12","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1007\/s11605-019-04457-w","article-title":"Is it feasible to standardize a composite postoperative complication reporting system for liver resection?","volume":"24","author":"Li","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2024.108733_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74067-z","article-title":"Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems","volume":"10","author":"Matsuda","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ejso.2024.108733_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejso.2024.108733_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107324","article-title":"Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: an exploratory subset analysis of JCOG1202","volume":"50","author":"Kobayashi","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108733_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamasurg.2013.2126","article-title":"Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy","volume":"148","author":"Fischer","year":"2013","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.ejso.2024.108733_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ags3.12682","article-title":"Phase I study of neoadjuvant S-1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: tosbic02)","volume":"7","author":"Abe","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ejso.2024.108733_bib18","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1245\/s10434-021-11206-4","article-title":"Impact of gemcitabine plus S1 neoadjuvant chemotherapy on borderline resectable perihilar cholangiocarcinoma","volume":"29","author":"Matsuyama","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108733_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-020-06895-1","article-title":"Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status","volume":"20","author":"Kuriyama","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.108733_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00423-023-03000-5","article-title":"Safety and efficacy of neoadjuvant chemotherapy based on our resectability criteria for locally advanced perihilar cholangiocarcinoma","volume":"408","author":"Gyoten","year":"2023","journal-title":"Langenbeck's Arch Surg"},{"issue":"5","key":"10.1016\/j.ejso.2024.108733_bib21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","article-title":"Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers","volume":"274","author":"Mueller","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.108733_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jhbp.914","article-title":"Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery for locally advanced cholangiocarcinoma: short- and long-term outcomes of superextended surgery","volume":"28","author":"Nagino","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"10.1016\/j.ejso.2024.108733_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ags3.12691","article-title":"Current progress in perioperative chemotherapy for biliary tract cancer","volume":"7","author":"Ioka","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"issue":"6","key":"10.1016\/j.ejso.2024.108733_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ags3.12734","article-title":"Essential updates 2021\/2022: update in surgical strategy for perihilar cholangiocarcinoma","volume":"7","author":"Kawano","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"issue":"31","key":"10.1016\/j.ejso.2024.108733_bib25","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"13","key":"10.1016\/j.ejso.2024.108733_bib26","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.ejso.2024.108733_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jamcollsurg.2012.08.030","article-title":"Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience","volume":"216","author":"Wolf","year":"2013","journal-title":"J Am Coll Surg"},{"issue":"7","key":"10.1016\/j.ejso.2024.108733_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hepr.12605","article-title":"Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: an updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry","volume":"46","author":"Mosadeghi","year":"2016","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.ejso.2024.108733_bib29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00268-018-04883-y","article-title":"Our rationale of initiating neoadjuvant chemotherapy for hilar cholangiocarcinoma: a proposal of criteria for \"borderline resectable\" in the field of surgery for hilar cholangiocarcinoma","volume":"43","author":"Matsuyama","year":"2019","journal-title":"World J Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832400790X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832400790X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:08:19Z","timestamp":1750504099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832400790X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S074879832400790X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108733","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of major hepatectomy following preoperative chemotherapy for advanced perihilar cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108733"}}